These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 13071952)

  • 1. [Hemolytic anemia studied in the light of results of new and modified methods of research].
    PAOLINO W
    Minerva Med; 1953 Apr; 44(28):907-23. PubMed ID: 13071952
    [No Abstract]   [Full Text] [Related]  

  • 2. [Electron microscope study of ferruginous granulations of normal and pathological erythrocytes; hemolytic anemias; hemoglobin disorders; saturnism].
    BESSIS M; BRETON-GORIUS J
    Rev Hematol; 1957; 12(1):43-63. PubMed ID: 13432371
    [No Abstract]   [Full Text] [Related]  

  • 3. [Synthesis of hemoglobin, RNA and DNA in hemolytic anemia, thalassemia and acute anemia following hemorrhage].
    Müller D; Boll M; Hahn E
    Acta Haematol; 1974; 51(1):19-28. PubMed ID: 4217071
    [No Abstract]   [Full Text] [Related]  

  • 4. [Hemolytic anemias and the diverse types of hemoglobin].
    LISTA GA
    Prensa Med Argent; 1955 Sep; 42(38):2959-64. PubMed ID: 13297645
    [No Abstract]   [Full Text] [Related]  

  • 5. [Research with the aid of radioactive chromium on hemolytic anemia patients].
    VEEGER W; WOLDRING MG; van ROOD J; EERNISSE JG; LEEKSMA CH; VERLOOP MC; NIEWEG HO
    Ned Tijdschr Geneeskd; 1961 Jul; 105():1472-6. PubMed ID: 13780560
    [No Abstract]   [Full Text] [Related]  

  • 6. [Association of hemoglobinosis and spherocytoanemia in a family with constitutional hemolytic anemia].
    GIGUENS WT; PACHECO-OLIVERA M; TEMESIO N; DRETS ME
    Arch Pediatr Urug; 1959 Aug; 30():477-86. PubMed ID: 13849966
    [No Abstract]   [Full Text] [Related]  

  • 7. [Classification of hemolytic anemias].
    Idel'son LI
    Ter Arkh; 1974; 46(8):91-9. PubMed ID: 4424261
    [No Abstract]   [Full Text] [Related]  

  • 8. [An electrophoretic hemoglobin abnormality, hitherto undescribed, in various congenital hemolytic disorders].
    BREURER M; DE VRIES A; PEKET L; MATOTH Y
    Sang; 1957; 28(4):323-34. PubMed ID: 13485953
    [No Abstract]   [Full Text] [Related]  

  • 9. Congenital hemolytic disease associated with red cell inclusion bodies, abnormal pigment metabolism and an electrophoretic hemoglobin abnormality.
    SCOTT JL; HAUT A; CARTWRIGHT GE; WINTROBE MM
    Blood; 1960 Sep; 16():1239-52. PubMed ID: 14444243
    [No Abstract]   [Full Text] [Related]  

  • 10. [Physiological and pathological features of the red blood cells and the hemoglobin as a principle for disease manifestations].
    BETKE K
    Dtsch Med Wochenschr; 1962 May; 87():909-14. PubMed ID: 13868622
    [No Abstract]   [Full Text] [Related]  

  • 11. [Observations on the erythrotropic activity of the serum and on the erythrocytic conglutination in hemolytic anemia (h. a.)].
    VISCA U; CASSI E; SUPPA G
    Boll Ist Sieroter Milan; 1961; 40():473-89. PubMed ID: 13926208
    [No Abstract]   [Full Text] [Related]  

  • 12. [Determinations of erythrocyte survival by the Cr-51 method in hemolytic anemia during therapy].
    SCHEITLIN W; FRICK P
    Schweiz Med Wochenschr; 1959 Dec; 89():1328-31. PubMed ID: 14442589
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinical determination of the sites of red cell sequestration in hemolytic anemias.
    JANDL JH; GREENBERG MS; YONEMOTO RH; CASTLE WB
    J Clin Invest; 1956 Aug; 35(8):842-67. PubMed ID: 13345887
    [No Abstract]   [Full Text] [Related]  

  • 14. [Studies on varied erythrocyte permeability for radioactive phosphorus in hemolytic anemia determined by immune bodies].
    LEHMANN J; GOSPOS H; NITSCH W
    Strahlentherapie; 1953; 89(4):573-9. PubMed ID: 13056844
    [No Abstract]   [Full Text] [Related]  

  • 15. [Splenohehaptic uptake and the average life of erythrocytes labeled with Cr-51 in hemolytic anemias in infancy].
    GOMIRATO SANDRUCCI M; NICOLA P; LANGE MM
    Minerva Nucl; 1960 Apr; 4():121-2. PubMed ID: 13850907
    [No Abstract]   [Full Text] [Related]  

  • 16. The use of Cr51 and Fe59 in a combined procedure to study erythrocyte production and destruction in normal human subjects and in patients with hemolytic or aplastic anemia.
    WEINSTEIN IM; BEUTLER E
    J Lab Clin Med; 1955 Apr; 45(4):616-22. PubMed ID: 14368025
    [No Abstract]   [Full Text] [Related]  

  • 17. In vitro erythrophagocytosis in acquired hemolytic anemia.
    ZINKHAM WH; DIAMOND LK
    Blood; 1952 Jun; 7(6):592-601. PubMed ID: 14925153
    [No Abstract]   [Full Text] [Related]  

  • 18. [Experimental hemolytic anemia induced by hetero-antisera. III. Variations in the lactic acid content of erythrocytes].
    PIPITONE V; RUSSO R; DAILLY L
    Boll Soc Ital Biol Sper; 1959 Oct; 35():1271-2. PubMed ID: 14433155
    [No Abstract]   [Full Text] [Related]  

  • 19. Studies on iron-protein metabolism with radioiron (Fe-55 and Fe-59).
    KATO I
    Jpn J Physiol; 1956 Feb; 5(Suppl):426-31. PubMed ID: 13318791
    [No Abstract]   [Full Text] [Related]  

  • 20. Physico-chemical mechanisms in the pathogenesis of certain hemolytic anemias.
    SHARPSTEEN JR
    Am J Med Sci; 1955 May; 229(5):506-16. PubMed ID: 14361417
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.